Judge effectiveness by metabolic outcomes like appetite suppression , weight loss , and glycemic control, not by injection site appearance
This review did not look at the effects of longer treatment periods
Descubrieron que las personas que reciban GLP-1 tenan menos probabilidades de sufrir anemia, cogulos de sangre en las venas, niveles bajos de glbulos blancos llamados neutrfilos, recuento bajo de plaquetas en sangre, septicemia, nuseas y vmitos , fatiga , miocardiopata y neuropata despus de la quimioterapia
This is exactly why the training and protein habits matter more than the medication itself
No, weight loss injections like semaglutide (Wegovy) do not increase heart attack or stroke risk and may actually reduce these events by 20% in patients with established cardiovascular disease and obesity, according to the SELECT trial